In a first, Japanese researchers have regenerated functional joints in frogs by activating a newly-found “reintegration” mechanism. Further understanding of this process may help transplanted tissues integrate with the original organs and limbs after surgical removal or amputation.
“We expect that by applying this approach to other animals, we may also achieve functional joint regeneration in mammals, including humans, in the future,” says Kyoto University study author Kiyokazu Agata.
Some animals — for instance newts — can regenerate a smaller, but fully functioning limb after the original has become detached. Frogs are considered to be the intermediate between such animals and mammals, that cannot regenerate limbs. Frogs regenerate “spikes”, which are cartilage rods protruding from the disfigured area. These new cartilage limbs lack joints, and are therefore unable to bend at will.
A functional joint requires integration of multiple tissues: two opposing skeletal elements forming an interlocking structure, and muscles which insert into skeletal tissues via tendons across joints. Newts, but not frogs, are capable of reconnecting these tissues.
When a frog limb is detached at an elbow joint, however, the interaction between the remaining and the regenerated tissues affects the regrowth of the regenerated elbow so that it resembles the original tissue more closely. As a result, the tissue attached to the joint is more similar in size to the original limb. The team named this interaction mechanism “reintegration”.
The researchers hope that further understanding of these mechanisms could ultimately bring about limb regeneration in mammals — and in the long run perhaps even humans.
“As a next step we would like to attempt functional joint regeneration in mice by activating the reintegration mechanism,” said Agata.
Read more: Regrowing functional joints in frogs
The Latest on: Regenerative medicine
[google_news title=”” keyword=”regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine
- APEX Biologix Appoints Jim Rogers as New Chief Executive Officeron January 16, 2023 at 6:05 am
The Board of Directors at APEX Biologix is pleased to announce a new Chief Executive Officer to continue the expansion and innovation efforts of the company. WOODS CROSS, Utah (PRWEB) January 16, 2023 ...
- Translational Regenerative Medicine Market 2023: Magnificent Analysis Report for Huge Growth by 2028on January 15, 2023 at 8:22 pm
Get a sample PDF of the report at The report providing scenario of history and present performance with an overview of successful marketing strategies, market contributions, and recent developments ...
- Regenerative Medicine Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Dataon January 14, 2023 at 4:42 am
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Regenerative Medicine ...
- Regenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical Ailmentson January 13, 2023 at 6:39 pm
Westford, USA, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The rising incidence of genetic abnormalities, the demand for organ transplants, and expanding R&D spending on regenerative medicine research are ...
- Ikudayisi: Regenerative Medicine Can Reduce Adverse Effects of COVID-19on January 13, 2023 at 4:00 pm
He is a United States Board Certified Internist and has passion for regenerative, aesthetic and cosmetic medicine. He spoke to Onyebuchi Ezigbo on what Nigerians stand to gain from the evolving ...
- Justice Department says defunct Westlake medical office overbilled $1.1 million for acupuncture deviceon January 13, 2023 at 12:27 pm
The U.S. Department of Justice entered into an agreement with a Westlake doctor's office over the office's overbilling of about $1.1 million to Medicare for acupuncture devices.
- Regenerative Medicine Global Market Report 2022: Featuring 3M, Allergan, Medtronic, Smith & Nephew, Stryker, Novartis & Moreon January 13, 2023 at 5:46 am
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market by Product (Cell Therapy (Autologous, Allogenic), Gene Therapy, Tissue Engineering ...
- Regenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical Ailmentson January 12, 2023 at 6:27 am
Westford, USA, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The rising incidence of genetic abnormalities, the demand for organ transplants, and expanding R&D spending on regenerative medicine research are some ...
- The Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic Conditionson January 9, 2023 at 8:34 am
MIAMI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Center for Regenerative Medicine (CRM) is paving the way with state-of-the-art, non-surgical treatments to help patients regain quality of life.
- REGENATIVE LABS PUBLISHES CASE STUDY DEMONSTRATING NEW APPLICATION OF WHARTON'S JELLY ALLOGRAFTS IN POST-SURGICAL BREAST REDUCTION CAREon January 9, 2023 at 3:41 am
Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal of Biomedical Research and Environmental Sciences alongside Dr. Alan Meglin, of Advanced ...
via Bing News